| Date Filed | Type | Description |
| 04/13/2023 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 5.1% stake in SCYNEXIS, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2023 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 6.1% stake in Praxis Precision Medicines, Inc. |
| 02/10/2022 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 9.3% stake in Applied Minerals, Inc. |
| 01/08/2021 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 10.5% stake in Applied Minerals, Inc. |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 3.1% stake in GTY Technology Holdings Inc. |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 7.4% stake in GTY Technology Holdings Inc. |
| 06/11/2018 |
SC 13D
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 10.6% stake in Applied Minerals, Inc. |
| 04/04/2018 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 5.1% stake in Eleven Biotherapeutics, Inc. |
| 04/02/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 4.8% stake in AIT Therapeutics, Inc. |
| 02/14/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 0% stake in Fate Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 3.4% stake in Heron Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 5.8% stake in Jaguar Animal Health, Inc. |
| 02/14/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 0% stake in Horizon Pharma Public Limited Company |
| 02/14/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 5% stake in Great Elm Capital Group, Inc. |
| 01/02/2018 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 12% stake in Applied Minerals, Inc. |
| 12/21/2017 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 11.9% stake in Applied Minerals, Inc. |
| 02/17/2017 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 6.1% stake in * Applied Minerals, Inc. |
| 02/14/2017 |
SC 13G/A
| Great Elm Capital Group, Inc. reports a 5.9% stake in Great Elm Capital Group, Inc. |
| 02/14/2017 |
SC 13G/A
| Applied Minerals, Inc. reports a 4.9% stake in Applied Minerals, Inc. |
| 02/14/2017 |
SC 13G
| Horizon Pharma plc reports a 7.8% stake in Horizon Pharma Public Limited Company |
| 02/14/2017 |
SC 13G/A
| FATE THERAPEUTICS INC reports a 7.7% stake in Fate Therapeutics, Inc. |
| 02/14/2017 |
SC 13G/A
| Jaguar Animal Health, Inc. reports a 9.3% stake in Jaguar Animal Health, Inc. |
| 02/14/2017 |
SC 13G/A
| Dipexium Pharmaceuticals, Inc. reports a 0% stake in Dipexium Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2017 |
SC 13G/A
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 1.8% stake in Tonix Pharmaceuticals Holding Corp. |
| 07/16/2013 |
SC 13D
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 7.4% stake in K-V Pharmaceutical Company |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| ACACIA RESEARCH CORP reports a 0% stake in Acacia Research Corporation |
|